Latest Administration News

Osmond Resources has secured a major foothold in Spain’s critical minerals sector, completing an 80% acquisition and advancing drilling at its Orión project with promising early results. Assay data and further drilling are poised to shape the project's next phase.

Wingara AG reports a modest cash position of $302,000 as it winds down processing operations and seeks fresh transaction opportunities following the termination of its TerraFirma deal.

Althea Group Holdings reported a resilient September quarter with $5.4 million in receipts despite a major strike in British Columbia, bolstered by a $2.53 million capital raise and expansion in the US THC beverage market.

Impact Minerals Limited reported a net cash outflow in operating and investing activities for Q3 2025 but strengthened its cash position through a significant equity raise, ending the quarter with nearly $5 million in cash.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

Future Metals NL appoints Keith Bowes as CEO and initiates a strategic review of its flagship Panton project, leveraging rising platinum group metal prices and exploration successes. The company also completes a A$4.2 million capital raise and plans to delist from AIM.

AUCyber Limited reports a rise in customer receipts and improved operating cash flow in Q1 FY26, following strategic exits from low-margin contracts and a focus on cybersecurity services.

Camplify Holdings reports a modest dip in revenue and transaction value due to poor weather, while maintaining positive cash flow and advancing its NSW TAP program rollout.

Pantera Lithium Limited has secured a significant 5,000-acre exploration footprint in Southwest Arkansas, targeting antimony and silver in a historically rich but long-neglected mining district. This move aligns with U.S. critical minerals priorities and leverages Pantera’s proven local expertise.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.